Transplantation
Reports from Urmia University add new data to research in transplantation
Published in Hospital Law Weekly, August 23rd, 2007
"We compared the efficacy of early low- versus high-dose cyclosporine (CsA) induction therapy in living donor renal transplantation. In this single-center study, 90 consecutive recipients of living donor kidney transplants between November 2002 to October 2003 including 51 females and mean average age of 48.23 years were treated with either CsA (5 mg/kg/d) plus mycophenolae mofetil (MMF; 30...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly
Source: Hospital Law Weekly (2007-08-23)
More Articles from Hospital Law Weekly
- Biotechnology Business
American Bio Medica Announces Second Quarter 2007 Results - Cord Blood
ViaCell Commends New York State on Recent Umbilical Cord Blood Legislation - Dartmouth Medical School
Postpartum hospital discharges -- when is the 'right time?' - Health Insurance
Consumer Reports Health Insurance Survey Reveals 1 in 4 People Insured but Not Adequately Covered - Health Management Associates, Inc.
Health Management Associates, Inc. Says Alleged Class Action Lawsuit is without Merit - Human Papillomavirus Vaccines
Researchers from University of Cincinnati report recent findings in human papillomavirus vaccines - More from this issue of Hospital Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
